These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 22724223)

  • 1. [Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH study].
    Miyauchi K
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():321-30. PubMed ID: 22724223
    [No Abstract]   [Full Text] [Related]  

  • 2. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
    Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
    Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Noninferiority of pitavastatin in intravascular ultrasound findings.
    Kaneda H; Ma J; Morita T
    J Am Coll Cardiol; 2010 Jan; 55(3):262-3; author reply 263. PubMed ID: 20117416
    [No Abstract]   [Full Text] [Related]  

  • 4. [Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome (JAPAN-aCS) study].
    Takeuchi T; Ota H; Hasebe N
    Nihon Rinsho; 2011 Nov; 69 Suppl 9():336-40. PubMed ID: 22724225
    [No Abstract]   [Full Text] [Related]  

  • 5. Qualitative plaque stabilization but not quantitative plaque regression.
    Nishigaki K
    Circ J; 2012; 76(4):809-11. PubMed ID: 22451448
    [No Abstract]   [Full Text] [Related]  

  • 6. Clinically evident polyvascular disease and regression of coronary atherosclerosis after intensive statin therapy in patients with acute coronary syndrome: serial intravascular ultrasound from the Japanese assessment of pitavastatin and atorvastatin in acute coronary syndrome (JAPAN-ACS) trial.
    Hibi K; Kimura T; Kimura K; Morimoto T; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Atherosclerosis; 2011 Dec; 219(2):743-9. PubMed ID: 21899843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diabetes mellitus is a major negative determinant of coronary plaque regression during statin therapy in patients with acute coronary syndrome--serial intravascular ultrasound observations from the Japan Assessment of Pitavastatin and Atorvastatin in Acute Coronary Syndrome Trial (the JAPAN-ACS Trial).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    Circ J; 2010 Jun; 74(6):1165-74. PubMed ID: 20467151
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Correlation between circulating adiponectin levels and coronary plaque regression during aggressive lipid-lowering therapy in patients with acute coronary syndrome: subgroup analysis of JAPAN-ACS study.
    Ohashi T; Shibata R; Morimoto T; Kanashiro M; Ishii H; Ichimiya S; Hiro T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura T; Daida H; Murohara T; Matsuzaki M
    Atherosclerosis; 2010 Sep; 212(1):237-42. PubMed ID: 20684825
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between circulating matrix metalloproteinase levels and coronary plaque regression after acute coronary syndrome--subanalysis of the JAPAN-ACS study.
    Ogita M; Miyauchi K; Morimoto T; Daida H; Kimura T; Hiro T; Nakagawa Y; Yamagishi M; Ozaki Y; Matsuzaki M
    Atherosclerosis; 2013 Jan; 226(1):275-80. PubMed ID: 23159100
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factors underlying regression of coronary atheroma with potent statin therapy.
    Puri R; Nissen SE; Ballantyne CM; Barter PJ; Chapman MJ; Erbel R; Libby P; Raichlen JS; St John J; Wolski K; Uno K; Kataoka Y; Nicholls SJ
    Eur Heart J; 2013 Jun; 34(24):1818-25. PubMed ID: 23644179
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comment on Stegman et al. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care 2014;37:3114-3120.
    Huang BT; Chen M
    Diabetes Care; 2015 Feb; 38(2):e27. PubMed ID: 25614700
    [No Abstract]   [Full Text] [Related]  

  • 12. Response to Comment on Stegman et al. High-intensity statin therapy alters the natural history of diabetic coronary atherosclerosis: insights from SATURN. Diabetes Care 2014;37:3114-3120.
    Stegman B; Puri R; Shao M; Nicholls SJ
    Diabetes Care; 2015 Feb; 38(2):e28-9. PubMed ID: 25614701
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparison of effects of atorvastatin (20 mg) versus rosuvastatin (10 mg) therapy on mild coronary atherosclerotic plaques (from the ARTMAP trial).
    Lee CW; Kang SJ; Ahn JM; Song HG; Lee JY; Kim WJ; Park DW; Lee SW; Kim YH; Park SW; Park SJ
    Am J Cardiol; 2012 Jun; 109(12):1700-4. PubMed ID: 22440123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo evaluation of atherosclerotic plaque inflammation and of anti-inflammatory effects of statins by 18F-fluorodeoxyglucose positron emission tomography.
    Gerber BL
    J Am Coll Cardiol; 2013 Sep; 62(10):918-20. PubMed ID: 23727087
    [No Abstract]   [Full Text] [Related]  

  • 15. [Series: Clinical study from Japan and its reflections: introduction and summary of results: the ESTABLISH study].
    Dohi T; Daida H
    Nihon Naika Gakkai Zasshi; 2011 Apr; 100(4):1100-6. PubMed ID: 21626852
    [No Abstract]   [Full Text] [Related]  

  • 16. Who benefits from statins? Patient or focal plaque?
    Fujii K; Masuyama T
    Circ J; 2012; 76(12):2744-5. PubMed ID: 23117744
    [No Abstract]   [Full Text] [Related]  

  • 17. Effect of intensive statin therapy on regression of coronary atherosclerosis in patients with acute coronary syndrome: a multicenter randomized trial evaluated by volumetric intravascular ultrasound using pitavastatin versus atorvastatin (JAPAN-ACS [Japan assessment of pitavastatin and atorvastatin in acute coronary syndrome] study).
    Hiro T; Kimura T; Morimoto T; Miyauchi K; Nakagawa Y; Yamagishi M; Ozaki Y; Kimura K; Saito S; Yamaguchi T; Daida H; Matsuzaki M;
    J Am Coll Cardiol; 2009 Jul; 54(4):293-302. PubMed ID: 19608026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of rosuvastatin and atorvastatin on the apolipoprotein B/apolipoprotein A-1 ratio in patients with an acute coronary syndrome: The CENTAURUS trial design.
    Lablanche JM; Danchin N; Farnier M; Tedgui A; Vicaut E; Alonso J; Crean P; Leone A; Morais J; Santini M; Licour M; Farah M; Tardif JC
    Arch Cardiovasc Dis; 2008 Jun; 101(6):399-406. PubMed ID: 18809153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dramatic reductions in plaque volumes on maximum statin therapy.
    Cardiovasc J Afr; 2011; 22(6):344-5. PubMed ID: 22159326
    [No Abstract]   [Full Text] [Related]  

  • 20. Statin loading for acute coronary syndromes.
    Nusca A; Melfi R; Patti G; Di Sciascio G
    Curr Opin Cardiol; 2010 Jul; 25(4):373-8. PubMed ID: 20520540
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.